«Batroxobin

Below is an extended Batroxobin patents listing. Click here to return to the Batroxobin main in depth entry.

Patents :
US Patent No.	Title
6399576	Method of inhibiting apoptosis
6630139	Fibrinogenolytic proteases with thrombolytic and antihypertensive activities: medical application and novel process of expression and production
6682520	Tissue volume reduction
6699484	Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
6713459	Methods for the prophylactic and therapeutic treatment of cardiac tissue damage
6740736	Purification of fibrinogen from milk by use of cation exchange chromatography
6750236	Propionic acid derivatives
6756214	Protein zlmda33
6758840	Drug delivery device
6822082	Polynucleotides for mammalian secreted protein, Z1055G2P
6841170	Process for preparing an autologous platelet gel and membrane thereof
6627215	Devices for improved wound management
6613325	Prevention of post surgical adhesions using a fibrin monomer sealant
6613324	Adhesive for the gluing of biological tissues
6416717	Evacuated blood collection tube for rapid blood coagulation
6462018	Fibrin polymer structure
6479052	Spray delivery of cells
6492494	Method of making a fibrin sealant comprising alpha-2-antiplasmin
6495051	Methods for preparing blood or plasma component solutions with improved concentrations
6503527	Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
6548538	Propionic acid derivatives
6551794	Stable biotinylated biomolecule composition
6558687	Fibrin polymer structure
6610043	Tissue volume reduction
6862470	Cavity-filling biopsy site markers
6914135	Kunitz domain polypeptide zkun10
7202048	Onset of force development as a marker of thrombin generation
7202230	Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity
7211650	Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography
7223365	Device and method for detecting the coagulation functions of global, especially primary hemostasis
7238828	Absorbable .alpha.-cyanoacrylate compositions
7279177	Hemostatic wound dressings and methods of making same
7300428	Tissue volume reduction
7345178	Sirtuin modulating compounds
7351787	Process for the preparation of activated polyethylene glycols
7357947	Bone graft material incorporating demineralized bone matrix and lipids
7189829	Baboon TAFI polypeptides
7183391	Kunitz domain polypeptide zkun10
7125558	Process for the preparation of activated polyethylene glycols
6921807	Proteinase inhibitor ZSERP9
6946079	Centrifugal filtration method for separating fibrin monomer from blood
6964868	Human genes and gene expression products II
6974800	Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor
6974805	Configuration of glycosaminoglycans
6979307	Systems and methods for preparing autologous fibrin glue
7019191	Hemostatic wound dressings and methods of making same
7030289	Stabilization of milk from transgenic animals
7091039	Kunitz domain polypeptide zkun6
7091331	Nucleic acid molecules and polypeptides encoding baboon TAFI
7405280	Chromogenic substances and use thereof for the determination of carboxypeptidase activities

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.